
PetIQ Inc
NASDAQ:PETQ

Net Margin
PetIQ Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
US |
![]() |
PetIQ Inc
NASDAQ:PETQ
|
925m USD |
1%
|
|
US |
![]() |
Mckesson Corp
NYSE:MCK
|
87.4B USD |
1%
|
|
US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
56.5B USD |
1%
|
|
US |
![]() |
Cencora Inc
NYSE:COR
|
55.8B USD |
1%
|
|
US |
![]() |
Cardinal Health Inc
NYSE:CAH
|
37.3B USD |
1%
|
|
AU |
![]() |
Sigma Healthcare Ltd
ASX:SIG
|
33.4B AUD |
0%
|
|
CN |
![]() |
Huadong Medicine Co Ltd
SZSE:000963
|
77.7B CNY |
8%
|
|
CN |
![]() |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
70.6B CNY |
2%
|
|
KR |
![]() |
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
7%
|
|
US |
![]() |
Henry Schein Inc
NASDAQ:HSIC
|
8.3B USD |
3%
|
|
AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
8.2B USD |
2%
|
PetIQ Inc
Glance View
PetIQ, Inc. is a holding company, which engages in the manufacture, procurement, packaging, and distribution of pet health and wellness products. The company is headquartered in Eagle, Idaho and currently employs 1,929 full-time employees. The company went IPO on 2017-07-21. The firm is engaged with customers through approximately 60,000 points of distribution across retail and e-commerce channels with its branded and distributed medications, as well as health and wellness items, which are further supported by its medications manufacturing facility in Omaha, Nebraska and health and wellness manufacturing facility in Springville, Utah. Its national veterinarian service platform operates in approximately 2,900 retail partner locations in 42 states provides veterinary wellness services. The firm has two segments: Products and Services. The Products segment consists of its manufacturing and distribution businesses. The Services segment consists of veterinary services and related product sales provided by the Company directly to consumers. Its products offering for dogs and cats includes pet Rx medications, OTC medications and wellness products.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on PetIQ Inc's most recent financial statements, the company has Net Margin of 1.2%.